Literature DB >> 30786044

Concordance for Parkinson's disease in twins: A 20-year update.

Samuel M Goldman1, Kenneth Marek2, Ruth Ottman3, Cheryl Meng4, Kathleen Comyns4, Piu Chan5, Jinghong Ma6, Connie Marras7, J William Langston8, G Webster Ross9, Caroline M Tanner10.   

Abstract

During the 1990s, we estimated the genetic contribution to Parkinson's disease risk in a large, population-based twin registry. Because many unaffected twins were still alive, previous concordance estimates were based on incomplete information. Ninety-five percent of twins are now deceased. Here, we update concordance and heritability through 2015 using National Death Index data. In total, we identified 30 concordant and 193 discordant pairs. Proband-wise concordance was 0.20 in monozygotic and 0.13 in dizygotic pairs. Heritability was 0.27 overall, 0.83 in pairs diagnosed ≤50, and 0.19 in pairs diagnosed >50. High concordance in dizygotic twins suggests shared effects of early childhood environment. Ann Neurol 2019;85:600-605.
© 2019 American Neurological Association.

Entities:  

Mesh:

Year:  2019        PMID: 30786044     DOI: 10.1002/ana.25441

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  16 in total

Review 1.  Can infections trigger alpha-synucleinopathies?

Authors:  Christopher T Tulisiak; Gabriela Mercado; Wouter Peelaerts; Lena Brundin; Patrik Brundin
Journal:  Prog Mol Biol Transl Sci       Date:  2019-07-03       Impact factor: 3.622

Review 2.  Parkinson Disease Epidemiology, Pathology, Genetics, and Pathophysiology.

Authors:  David K Simon; Caroline M Tanner; Patrik Brundin
Journal:  Clin Geriatr Med       Date:  2019-08-24       Impact factor: 3.076

Review 3.  Post-GWAS knowledge gap: the how, where, and when.

Authors:  Steven E Pierce; Alix Booms; Jordan Prahl; Edwin J C van der Schans; Trevor Tyson; Gerhard A Coetzee
Journal:  NPJ Parkinsons Dis       Date:  2020-09-09

4.  Well Water and Parkinson's Disease in Medicare Beneficiaries: A Nationwide Case-Control Study.

Authors:  Maya R Silver; Brad A Racette; Umber Dube; Irene M Faust; Susan Searles Nielsen
Journal:  J Parkinsons Dis       Date:  2020       Impact factor: 5.568

Review 5.  Polygenic risk and pleiotropy in neurodegenerative diseases.

Authors:  Eftychia Bellou; Joshua Stevenson-Hoare; Valentina Escott-Price
Journal:  Neurobiol Dis       Date:  2020-05-20       Impact factor: 5.996

Review 6.  The interplay of aging, genetics and environmental factors in the pathogenesis of Parkinson's disease.

Authors:  Shirley Yin-Yu Pang; Philip Wing-Lok Ho; Hui-Fang Liu; Chi-Ting Leung; Lingfei Li; Eunice Eun Seo Chang; David Boyer Ramsden; Shu-Leong Ho
Journal:  Transl Neurodegener       Date:  2019-08-16       Impact factor: 8.014

7.  α-Synuclein oligomers in skin biopsy of idiopathic and monozygotic twin patients with Parkinson's disease.

Authors:  Samanta Mazzetti; Milo J Basellini; Valentina Ferri; Erica Cassani; Emanuele Cereda; Matilde Paolini; Alessandra M Calogero; Carlotta Bolliri; Mara De Leonardis; Giorgio Sacilotto; Roberto Cilia; Graziella Cappelletti; Gianni Pezzoli
Journal:  Brain       Date:  2020-03-01       Impact factor: 13.501

8.  Dietary intake and plasma levels of polyunsaturated fatty acids in early-stage Parkinson's disease.

Authors:  Dallah Yoo; Yunsook Lim; Yiseul Son; Hyunkyung Rho; Chaewon Shin; Tae-Beom Ahn
Journal:  Sci Rep       Date:  2021-06-14       Impact factor: 4.379

Review 9.  Advancing Personalized Medicine in Common Forms of Parkinson's Disease through Genetics: Current Therapeutics and the Future of Individualized Management.

Authors:  Xylena Reed; Artur Schumacher-Schuh; Jing Hu; Sara Bandres-Ciga
Journal:  J Pers Med       Date:  2021-03-01

Review 10.  The Genetics of Parkinson's Disease and Implications for Clinical Practice.

Authors:  Jacob Oliver Day; Stephen Mullin
Journal:  Genes (Basel)       Date:  2021-06-30       Impact factor: 4.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.